SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Miller who wrote (2066)3/22/1999 3:59:00 PM
From: Don Miller  Read Replies (1) of 10280
 
Doing a little more information mining of the SI posts, WOW you guys are good.

While mining information about the LLY trial with Barr I somehow came across the mention of SEPR working with SNAP on a migraine drug. I was unaware SEPR might also be working a partnership with SNAP for a migraine drug.

Is it possible the SNAP drug LLY canceled Friday before doing PhaseIII is (S)-fluoxetine, and without mentioning SEPR? Somebody on one of these boards said they were going to delay (S)-fluoxetine so they could concentrate on (R)-fluoxetine.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext